Triton 1.5 Robotic System for Diagnostic Colonoscopy (NCT07606963) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Triton 1.5 Robotic System for Diagnostic Colonoscopy
Poland40 participantsStarted 2026-08-01
Plain-language summary
This study is a prospective, single-arm, non-randomized, single-site study, focused on evaluating the safety and efficacy of the Triton 1.5 System in diagnostic and basic therapeutic colonoscopy.
Who can participate
Age range
22 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥ 22 years
. Adults indicated for elective screening, surveillance or diagnostic colonoscopy
. Subject is willing and able to provide written informed consent prior to receiving any non-standard of care protocol specific procedures
. Subject is willing and able to comply with all protocol required preparation and follow- up visits
Exclusion criteria
. Any medical or physical condition/limitation that would contraindicate a conventional colonoscopy. This assessment will be made by the investigator.
. Any active or magnetic implantable medical devices (e.g., pacemakers, defibrillators)
. Previous failed colonoscopy (except for inadequate bowel preparation)
. BMI \> 45 kg/m2
. Pregnant participants, women of reproductive potential (pre-menopausal and/or no history of hysterectomy), confirmed by a positive pregnancy test (serum).
. Surgically altered colonic anatomy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Primary Safety Endpoint - Incident of Major Adverse Events within 48 Hours
Timeframe: 48 Hours
2
Primary Efficacy Endpoint - Successful Completion of Colonoscopy During Procedure
. History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, hereditary nonpolyposis colorectal cancer (Lynch) syndrome, sclerosing encapsulating peritonitis, active diverticulitis in last 6 months or toxic megacolon
. Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day